Clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment programs for the treatment and management of chronic epilepsy require individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, and multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological disorders that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of chronic OCECPEO. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.